BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Guo AT, Song X, Wei LX, Zhao P. Histological origin of pseudomyxoma peritonei in Chinese women: Clinicopathology and immunohistochemistry. World J Gastroenterol 2011; 17(30): 3531-3537 [PMID: 21941421 DOI: 10.3748/wjg.v17.i30.3531] [Cited by in CrossRef: 17] [Cited by in F6Publishing: 16] [Article Influence: 1.5] [Reference Citation Analysis]
Number Citing Articles
1 Nummela P, Leinonen H, Järvinen P, Thiel A, Järvinen H, Lepistö A, Ristimäki A. Expression of CEA, CA19-9, CA125, and EpCAM in pseudomyxoma peritonei. Human Pathology 2016;54:47-54. [DOI: 10.1016/j.humpath.2016.02.022] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 2.0] [Reference Citation Analysis]
2 Ramaswamy V. Pathology of mucinous appendiceal tumors and pseudomyxoma peritonei. Indian J Surg Oncol. 2016;7:258-267. [PMID: 27065718 DOI: 10.1007/s13193-016-0516-2] [Cited by in Crossref: 26] [Cited by in F6Publishing: 23] [Article Influence: 4.3] [Reference Citation Analysis]
3 Wang H, Wang X, Ju Y, Wang J, Zhang X, Cheng Y, Sun J, Hu Y. Clinicopathological features and prognosis of pseudomyxoma peritonei. Exp Ther Med 2014;7:185-90. [PMID: 24348787 DOI: 10.3892/etm.2013.1408] [Cited by in Crossref: 10] [Cited by in F6Publishing: 5] [Article Influence: 1.1] [Reference Citation Analysis]
4 Lin YL, Ma R, Li Y. The biological basis and function of GNAS mutation in pseudomyxoma peritonei: a review. J Cancer Res Clin Oncol 2020;146:2179-88. [PMID: 32700107 DOI: 10.1007/s00432-020-03321-8] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
5 Guo AT, Li YM, Wei LX. Pseudomyxoma peritonei of 92 Chinese patients: Clinical characteristics, pathological classification and prognostic factors. World J Gastroenterol 2012; 18(24): 3081-3088 [PMID: 22791943 DOI: 10.3748/wjg.v18.i24.3081] [Cited by in CrossRef: 16] [Cited by in F6Publishing: 13] [Article Influence: 1.6] [Reference Citation Analysis]
6 Wei WC, Zhang CP, Zhang Q, Wang XW, Zhang HZ, Zhao K, Tian ZB. Expression of Hippo signaling molecules in gastric carcinogenesis. Shijie Huaren Xiaohua Zazhi 2012; 20(31): 3027-3032 [DOI: 10.11569/wcjd.v20.i31.3027] [Cited by in CrossRef: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
7 Carr NJ. Current concepts in pseudomyxoma peritonei. Ann Pathol 2014;34:9-13. [PMID: 24630632 DOI: 10.1016/j.annpat.2014.01.011] [Cited by in Crossref: 14] [Cited by in F6Publishing: 11] [Article Influence: 1.8] [Reference Citation Analysis]
8 Amini A, Masoumi-Moghaddam S, Ehteda A, Morris DL. Secreted mucins in pseudomyxoma peritonei: pathophysiological significance and potential therapeutic prospects. Orphanet J Rare Dis. 2014;9:71. [PMID: 24886459 DOI: 10.1186/1750-1172-9-71] [Cited by in Crossref: 31] [Cited by in F6Publishing: 26] [Article Influence: 3.9] [Reference Citation Analysis]
9 Azzakhmam M, Zouaidia F, Jahid A, Znati K, Bernoussi Z, Mahassini N. [Recurrence of pseudomyxoma peritonei with liver and splenic metastases: about a case and literature review]. Pan Afr Med J 2018;30:225. [PMID: 30574243 DOI: 10.11604/pamj.2018.30.225.15484] [Reference Citation Analysis]
10 El-Esawy BH, Abd El Hafez A, Abdelaziz AM. Clinicopathological Criteria Defining Mucinous Appendiceal Tumors from 2476 Appendectomies: a Single-Center Retrospective Study. J Gastrointest Cancer 2020;51:10-6. [PMID: 30484138 DOI: 10.1007/s12029-018-0182-4] [Reference Citation Analysis]
11 Yan F, Shi F, Li X, Yu C, Lin Y, Li Y, Jin M. Clinicopathological Characteristics of Pseudomyxoma Peritonei Originated from Ovaries.Cancer Manag Res. 2020;12:7569-7578. [PMID: 32904568 DOI: 10.2147/CMAR.S264474] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
12 Wu W, Hu Z, Zhao Q, Zhang X, Zhang H, Wang H, Xue W, Yu L, Duan G. Down-Regulation of Hypoxia-Inducible Factor-1α and Downstream Glucose Transporter Protein-1 Gene by β-elemene Enhancing the Radiosensitivity of Lung Adenocarcinoma Transplanted Tumor. Onco Targets Ther 2020;13:11627-35. [PMID: 33223837 DOI: 10.2147/OTT.S275956] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
13 Agrawal AK, Bobiński P, Grzebieniak Z, Rudnicki J, Marek G, Kobielak P, Kazanowski M, Agrawal S, Hałoń A. Pseudomyxoma peritonei originating from urachus-case report and review of the literature. Curr Oncol 2014;21:e155-65. [PMID: 24523614 DOI: 10.3747/co.21.1695] [Cited by in Crossref: 26] [Cited by in F6Publishing: 21] [Article Influence: 3.3] [Reference Citation Analysis]
14 Pandya R, Grace San Diego K, Shabbir T, Modi AP, Wang J, Dhahbi J, Barsky SH. The cell of cancer origin provides the most reliable roadmap to its diagnosis, prognosis (biology) and therapy. Med Hypotheses 2021;157:110704. [PMID: 34688214 DOI: 10.1016/j.mehy.2021.110704] [Reference Citation Analysis]
15 Badyal RK, Khairwa A, Rajwanshi A, Nijhawan R, Radhika S, Gupta N, Dey P. Significance of epithelial cell clusters in pseudomyxoma peritonei.Cytopathology. 2016;27:418-426. [PMID: 27121698 DOI: 10.1111/cyt.12331] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
16 Suh DS, Song YJ, Kwon BS, Lee S, Lee NK, Choi KU, Kim KH. An unusual case of pseudomyxoma peritonei associated with synchronous primary mucinous tumors of the ovary and appendix: A case report.Oncol Lett. 2017;13:4813-4817. [PMID: 28599482 DOI: 10.3892/ol.2017.6079] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
17 Han XD, Zhou N, Lu YY, Xu HB, Guo J, Liang L. Pseudomyxoma peritonei originating from intestinal duplication: A case report and review of the literature. World J Clin Cases 2021; 9(25): 7459-7467 [PMID: 34616812 DOI: 10.12998/wjcc.v9.i25.7459] [Reference Citation Analysis]